Stability indicating RP-HPLC method for the simultaneous estimation of Trastuzumab and Pembrolizumab in pharmaceutical dosage forms

Author:

Sahithi Alapati1,Asha Deepti Choppala1

Affiliation:

1. Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Visakhapatnam, India.

Abstract

Trastuzumab and Pembrolizumab, are both integral to cancer treatment. This study focused on the development of a Reverse-phase high-performance liquid chromatography technique that has been validated for simultaneous assay of Trastuzumab and Pembrolizumab using Luna Phenyl Hexyl column with UV detection at 215 nm, and the run time is 5 minutes. The retention times for Trastuzumab 2.730 min and Pembrolizumab 4.468 min were determined. The method exhibited a concentration range of 110–660 μg/ml for Trastuzumab and 12.50–75 μg/ml for Pembrolizumab. The Limit of Detection and Limit of Quantification were determined to be 0.66μg/ml and 2μg/ml for Trastuzumab,0.075 μg/ml and 0.25 μg/ml for Pembrolizumab, respectively.

Publisher

A and V Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3